Related Experiment Video
Updated: May 3, 2026

Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins
Published on: September 30, 2014
Detection of Macrolide-Resistant Streptococcus pneumoniae Genes and Its Clinical Outcomes in a Tertiary Teaching
Wan Norliyana Wan Mahmud1, Siti Asma' Hassan2, Zaidah Abd Rahman2
1Hospital Kemaman, Terengganu, Malaysia.
Background:
Streptococcus pneumoniae is one of the leading causes of mortality and morbidity worldwide. The dramatic increase in in-vitro resistance of antimicrobial agents, particularly beta-lactams and macrolides, makes pneumococcal infections difficult to treat. The aim of this study was to describe the drug resistance rate, assess the prevalence of macrolide-resistant genes and review the clinical complications of pneumococcal infections among patients presented to Hospital Universiti Sains Malaysia (HUSM), Kelantan, Malaysia.
Methods:
This is a descriptive cross-sectional study. All S. pneumoniae isolates collected from clinical specimens within a 1-year period were subjected to selected antimicrobial susceptibility testing using E-test strips. Polymerase chain reaction (PCR) analysis was conducted to detect macrolide-resistant determinants. The patient's clinical data were obtained from clinical notes.
Results:
A total of 113 patients with a positive growth of S. pneumoniae were included in the study. The most common predisposing factors among them were bronchopulmonary diseases (15.9%). The penicillin-resistant rate was 7.1%, with minimal inhibitory concentration (MIC) ranging between 0.012 μg/mL and >32 μg/mL, and the erythromycin-resistant rate was 26.5%, with a MIC range of 0.03 μg/mL-> 256 μg/mL. Most of the erythromycin-resistant isolates were found to have the mef(A) gene (50.4%) and the erm(B) gene (20%); 16.7% had a combination of genes mef(A) and erm(B), and 13.3% had none of the two genes. Community-acquired pneumonia is the predominant type of pneumococcal infection. There was no significant association between the presence of macrolide resistance determinants and mortality (P = 0.837) or complications (P > 0.999 for empyema and cardiac complication; P = 0.135 for subdural abscess).
Conclusion:
The majority of erythromycin-resistant isolates were found to have the mef(A) gene, followed by the erm(B) gene and a combination of genes mef(A) and erm(B).
Insights
Drug-resistant Streptococcus pneumoniae poses a significant global health threat. This study found macrolide resistance in pneumococcal infections, primarily linked to the mef(A) gene, without impacting mortality or complications.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Streptococcus pneumoniae causes significant global mortality and morbidity.
- Increasing antimicrobial resistance, especially to beta-lactams and macrolides, complicates pneumococcal infection treatment.
- This study investigated drug resistance and macrolide-resistant genes in pneumococcal infections at Hospital Universiti Sains Malaysia.
Purpose of the Study:
- To determine the drug resistance rates of Streptococcus pneumoniae isolates.
- To assess the prevalence of macrolide-resistant genes in these isolates.
- To review the clinical complications associated with pneumococcal infections.
Main Methods:
- Descriptive cross-sectional study design.
- Antimicrobial susceptibility testing using E-test strips for S. pneumoniae isolates.
- Polymerase chain reaction (PCR) to detect macrolide-resistant determinants (mef(A) and erm(B)).
Main Results:
- Penicillin resistance was 7.1% and erythromycin resistance was 26.5%.
- The mef(A) gene was the most prevalent macrolide resistance determinant (50.4%), followed by erm(B) (20%).
- No significant association was found between macrolide resistance determinants and mortality or specific complications.
Conclusions:
- The mef(A) gene is the primary driver of macrolide resistance in S. pneumoniae isolates studied.
- Erythromycin-resistant isolates frequently carried mef(A), erm(B), or both.
- Understanding resistance patterns is crucial for effective pneumococcal infection management.
Related Concept Videos
Pneumonia III: Complications and Assessment
Development of Antibiotic Resistance
Atypical Pneumonia
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance

